Nancy Wysenski

Affiliations

  • Director at Cytokinetics Inc (CYTK), 2024-10-03
  • Director at Alkermes Plc. (ALKS), 2023-07-11
  • Director at Provention Bio Inc. (PRVB), 2023-04-27
  • Director at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
  • Director at Tetraphase Pharmaceuticals Inc (TTPH), 2019-06-11
  • Director at Inovio Pharmaceuticals Inc. (INO), 2016-05-16
  • Evp, Chief Commercial Officer at Vertex Pharmaceuticals Inc / Ma (VRTX), 2012-06-01
  • Officer at Endo Pharmaceuticals Holdings Inc (ENDP), 2009-03-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALKS $19.65 6,940 Director 11,242 2020-02-24 Filing
ALKS $33.06 445 Director 4,302 2019-03-14 Filing
ALKS $33.09 3,857 Director 3,857 2019-02-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALKS $31.24 41,250 Director 15,829 2023-05-09 Filing
VRTX $65.00 372 Officer 32,232 2012-05-14 Filing
VRTX $64.27 179,628 Officer 32,604 2012-05-14 Filing
VRTX $65.00 372 Officer 32,232 2012-05-14 Filing
VRTX $64.27 179,628 Officer 32,604 2012-05-14 Filing